BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:UTAA91 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of UTAA91\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06982547-5467@assetmemo.bio
DTSTAMP:20261121T004018Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:UTAA91: Phase 1 readout est. (NCT06982547)
DESCRIPTION:UTAA91\, phase 1\, Rheumatoid Arthritis.\nStudy: Clinical Study
  on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection
 \nEstimated primary completion: December 2027. This is a ClinicalTrials.go
 v estimate\, not a confirmed readout date\, and it can move.\nDrug page: h
 ttps://assetmemo.bio/drug/utaa91#upcoming-events\nRegistry record: https:/
 /clinicaltrials.gov/study/NCT06982547
URL:https://assetmemo.bio/drug/utaa91#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06982534-5467@assetmemo.bio
DTSTAMP:20261121T004018Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:UTAA91: Phase 1 readout est. (NCT06982534)
DESCRIPTION:UTAA91\, phase 1.\nStudy: Clinical Study on the Treatment of Sy
 stemic Sclerosis With UTAA91 Injection.\nEstimated primary completion: Dec
 ember 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readou
 t date\, and it can move.\nDrug page: https://assetmemo.bio/drug/utaa91#up
 coming-events\nRegistry record: https://clinicaltrials.gov/study/NCT069825
 34
URL:https://assetmemo.bio/drug/utaa91#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07000682-5467@assetmemo.bio
DTSTAMP:20261121T004018Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:UTAA91: Phase 1 readout est. (NCT07000682)
DESCRIPTION:UTAA91\, phase 1.\nStudy: The Clinical Study on the Treatment o
 f SSc With UTAA91 Injection.\nEstimated primary completion: December 2027.
  This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, an
 d it can move.\nDrug page: https://assetmemo.bio/drug/utaa91#upcoming-even
 ts\nRegistry record: https://clinicaltrials.gov/study/NCT07000682
URL:https://assetmemo.bio/drug/utaa91#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07001956-5467@assetmemo.bio
DTSTAMP:20261121T004018Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:UTAA91: Phase 1 readout est. (NCT07001956)
DESCRIPTION:UTAA91\, phase 1\, Rheumatoid Arthritis.\nStudy: The Clinical S
 tudy on the Treatment of Refractory RA With UTAA91 Injection\nEstimated pr
 imary completion: December 2027. This is a ClinicalTrials.gov estimate\, n
 ot a confirmed readout date\, and it can move.\nDrug page: https://assetme
 mo.bio/drug/utaa91#upcoming-events\nRegistry record: https://clinicaltrial
 s.gov/study/NCT07001956
URL:https://assetmemo.bio/drug/utaa91#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
